Analyse des signes cliniques des malades atteints de pemphigoïde en fonction des antigènes reconnus par leur sérum en immunotransfert

[1]  M. Meurer,et al.  Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. , 2002, Archives of dermatology.

[2]  P. Courville,et al.  Extensive erosive bullous pemphigoid: an atypical and serious clinical variant , 2002, The British journal of dermatology.

[3]  L. Vaillant,et al.  A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. , 2002, The New England journal of medicine.

[4]  P. Courville,et al.  [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies]. , 2000, Annales de pathologie.

[5]  E. Bröcker,et al.  Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. , 2000, Archives of dermatology.

[6]  J. Roujeau,et al.  Lichenoid erythrodermic bullous pemphigoid of the African patient. , 1998, Journal of the American Academy of Dermatology.

[7]  L. Vaillant,et al.  Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. , 1998, Archives of dermatology.

[8]  J. Roujeau,et al.  High risk of death in elderly patients with extensive bullous pemphigoid. , 1998, Archives of dermatology.

[9]  S. M. Ewing,et al.  A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. , 1997, The Journal of investigative dermatology.

[10]  R. Ghohestani,et al.  Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2) , 1997, The British journal of dermatology.

[11]  P. Courville,et al.  Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid. , 1997, Archives of dermatology.

[12]  J. Bonnetblanc,et al.  Anti‐BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients , 1997, The British journal of dermatology.

[13]  L. Vaillant,et al.  Drugs Associated With Bullous Pemphigoid: A Case-Control Study , 1996 .

[14]  T. Nishikawa,et al.  Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles , 1996, Clinical and experimental dermatology.

[15]  Jean Kanitakis,et al.  BPAg2 antibodies are present at lower levels than BPAg1 antibodies in serum from patients with bullous pemphigoid , 1996 .

[16]  S. G. Woods,et al.  Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid , 1995, The British journal of dermatology.

[17]  E. Bröcker,et al.  Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. , 1995, Archives of dermatology.

[18]  L. Vaillant,et al.  Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions , 1995 .

[19]  L. Vaillant,et al.  Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. , 1995, Archives of dermatology.

[20]  C. Lebbé,et al.  Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. , 1994, The Journal of investigative dermatology.

[21]  J. Troy,et al.  A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. , 1993, The Journal of clinical investigation.

[22]  K. Owaribe,et al.  HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. , 1993, Journal of biochemistry.

[23]  F. Tron,et al.  Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? , 1993, Journal of the American Academy of Dermatology.

[24]  J. Bonnetblanc,et al.  Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. , 1990, Clinical immunology and immunopathology.

[25]  J. Saurat,et al.  Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. , 1989, The Journal of investigative dermatology.

[26]  D. Roop,et al.  Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. , 1988, The Journal of clinical investigation.

[27]  N. Ling,et al.  Subclass distribution of IgG autoantibodies in bullous pemphigoid. , 1986, The Journal of investigative dermatology.

[28]  T. Flotte,et al.  Immunoglobulin light and heavy chain isotypes in skin diseases: restricted distribution in bullous pemphigoid and linear IgA bullous dermatosis. , 1986, Journal of immunology.

[29]  N. Levine,et al.  Localized pemphigoid simulating dyshidrosiform dermatitis. , 1979, Archives of dermatology.

[30]  H. Perry,et al.  Benign Pemphigoid?: A Report of Seven Cases with Chronic, Scarring, Herpetiform Plaques About the Head and Neck , 1957 .